
Beyond Precision: The Inexorable Rise of N-of-1 Personalized Oncology
The lack of clinical access to N-of-1 personalized treatment for those hosting advanced cancer is a downstream crisis that rivals our upstream failure in comprehensive prevention through lifestyle and behavioral change. For decades, oncology has revolved around the drug rather than the patient, treating organs







